Literature DB >> 31748911

Impact of Smoking and Smoking Cessation Medications in Aviators.

Jason I Dailey1,2, Kristopher C Wilson3.   

Abstract

PURPOSE OF REVIEW: To (1) compare the effects of cigarette smoking, nicotine withdrawal, and smoking cessation medications in US civilian and military aviators and (2) review the regulations in place regarding the use of smoking cessation medications for US aviators. RECENT
FINDINGS: Cigarette smoking and associated cessation attempts are associated with multiple hazards in flight to aviators including effects from nicotine intoxication, nicotine withdrawal, carbon monoxide intoxication, and side effects related to smoking cessation medications. Current civilian and military regulations place significant restrictions on the use of smoking cessation medications to aviators; however, recent research suggests that the hazards associated with these medications might be lower than the risk-associated unassisted nicotine withdrawal. An evidence-based approach to smoking cessation may require changing restrictions against smoking cessation medication use in US civilian and military aviators. Use and cessation of smokeless tobacco and e-cigarettes require additional attention and research in this population.

Entities:  

Keywords:  Aviation; Bupropion; Nicotine; Smoking cessation; Varenicline

Mesh:

Substances:

Year:  2019        PMID: 31748911     DOI: 10.1007/s11920-019-1109-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  18 in total

1.  Psychomotor performance in smokers following single and repeated doses of nicotine gum.

Authors:  N Sherwood; J S Kerr; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Smoking cessation therapy and the return of aviators to flying duty.

Authors:  Alon Grossman; Dan-Avi Landau; Erez Barenboim; Liav Goldstein
Journal:  Aviat Space Environ Med       Date:  2005-11

3.  Influence of nicotine on simulator flight performance in non-smokers.

Authors:  M S Mumenthaler; J L Taylor; R O'Hara; J A Yesavage
Journal:  Psychopharmacology (Berl)       Date:  1998-11       Impact factor: 4.530

4.  Nicotine deprivation and pilot performance during simulated flight.

Authors:  Martin S Mumenthaler; Neal L Benowitz; Joy L Taylor; Leah Friedman; Art Noda; Jerome A Yesavage
Journal:  Aviat Space Environ Med       Date:  2010-07

5.  Quitting Smoking Among Adults - United States, 2000-2015.

Authors:  Stephen Babb; Ann Malarcher; Gillian Schauer; Kat Asman; Ahmed Jamal
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-06       Impact factor: 17.586

6.  Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects.

Authors:  Martin S Mumenthaler; Jerome A Yesavage; Joy L Taylor; Ruth O'Hara; Leah Friedman; Hana Lee; Helena C Kraemer
Journal:  Neuropsychopharmacology       Date:  2003-05-14       Impact factor: 7.853

Review 7.  Acute effects of cigarette smoking withdrawal: a review of the literature.

Authors:  T Sommese; J C Patterson
Journal:  Aviat Space Environ Med       Date:  1995-02

8.  Acute effects of nicotine withdrawal syndrome in pilots during flight.

Authors:  George Giannakoulas; Angelos Katramados; Nikolaos Melas; Ioannis Diamantopoulos; Elias Chimonas
Journal:  Aviat Space Environ Med       Date:  2003-03

9.  Short- and long-term effects of smoking on arterial wall properties in habitual smokers.

Authors:  M J Kool; A P Hoeks; H A Struijker Boudier; R S Reneman; L M Van Bortel
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094

10.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Authors:  Robert M Anthenelli; Neal L Benowitz; Robert West; Lisa St Aubin; Thomas McRae; David Lawrence; John Ascher; Cristina Russ; Alok Krishen; A Eden Evins
Journal:  Lancet       Date:  2016-04-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.